HOME > REGULATORY
REGULATORY
- Editor’s Pick: Five Healthcare News Headlines for July 6 - July 20
July 21, 2015
- PAFSC’s First Committee to Discuss Actelion’s Tracleer, Other Products on July 31
July 21, 2015
- Filings for Investigator-Led Trials Log 6-Fold Increase in 6 Years: PMDA Official
July 17, 2015
- Government’s Council Finalizes Policy Proposal for Promoting Genomic Medicines for Rare Diseases, Diabetes
July 16, 2015
- Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 2
July 15, 2015
- MHLW Starts Seeking Drug Development Requests under New Scheme
July 14, 2015
- Council OKs Applications Based on Data from Public Domain for 3 Drugs Including Lidocaine
July 14, 2015
- Govt, Pharma Leaders to Meet in August for Drafting of “Comprehensive Strategy”
July 13, 2015
- Q&A Document on GMP for APIs Reaches Step 4: ICH Meeting in Fukuoka
July 13, 2015
- MHLW to Seek “Candidate Drug Lists” for Patient-Initiated Mixed Care from Medical Societies
July 9, 2015
- FY2015 Survey on Generic Use to Get Underway, Results Out in Autumn
July 9, 2015
- JPMA to Cooperate in AMED’s DISC Project: President
July 9, 2015
- Govt to Stockpile Enough Cell Culture-Based H5N1 Pre-Pandemic Vaccines from Kaketsuken for 2.5 Million People
July 9, 2015
- Heart Failure Added to Clinically Significant ADR List for Xalkori
July 8, 2015
- MHLW Calls for Revision of Package Insert for Influenza HA Vaccine, Others
July 8, 2015
- Drug Pricing Tomorrow: Full Interview with MHLW Economic Affairs Head Jo - Part 1
July 8, 2015
- Govt to Stockpile Pre-Pandemic Flu Vaccine Based on Indonesia Strain in FY2015
July 7, 2015
- Editor’s Pick: Five Healthcare News Headlines for June 22 - July 5
July 6, 2015
- MHLW Approves Gilead’s Harvoni, Other Products
July 6, 2015
- NCC Eyes Trial Enrollment of 150 Rare Cancer Patients under Registry Initiative
July 3, 2015
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
